Energy Recovery, Inc. 2023 Form 10-K Summary
Business context and reporting period
Energy Recovery, Inc. designs and manufactures pressure-exchanger energy-efficiency products for seawater desalination, wastewater treatment and emerging applications, including CO2-based commercial refrigeration. Reportable segments are Water and Emerging Technologies. This filing covers the fiscal year ended December 31, 2023; it is an annual filing rather than a standalone 2023 fourth-quarter report.
The company generated 98% of revenue internationally. Its principal products include PX pressure exchangers, Ultra PX and low-pressure PX products, hydraulic turbochargers, pumps and the PX G1300 refrigeration product. Water remains the dominant business, while wastewater and refrigeration are the principal diversification opportunities.
Key financial metrics
| Metric | 2023 | 2022 | Change |
|---|---|---|---|
| Revenue | $128.3 million | $125.6 million | +$2.8 million, or 2% |
| Gross profit | $87.1 million | $87.4 million | -$0.3 million |
| Gross margin | 67.8% | 69.6% | -1.8 percentage points |
| Income from operations | $19.1 million | $24.8 million | -$5.8 million |
| Net income | $21.5 million | $24.0 million | -$2.5 million |
| Diluted EPS | $0.37 | $0.42 | Down |
| Net cash provided by operating activities | $26.1 million | $12.6 million | +$13.4 million |
| Capital expenditures | $2.6 million | $4.2 million | -$1.7 million |
Revenue by channel was $83.7 million from megaprojects, $26.0 million from OEM customers and $18.7 million from aftermarket customers. Megaproject revenue increased 2%, OEM revenue declined 10%, and aftermarket revenue increased 26%.
Water revenue was $127.7 million, compared with $125.4 million in 2022. Emerging Technologies revenue increased to $0.6 million from $0.2 million, primarily from CO2 refrigeration growth. The Water segment generated $61.7 million of operating income, while Emerging Technologies reported an operating loss of $23.1 million.
At December 31, 2023, the company had $68.1 million of cash and cash equivalents, $54.3 million of short- and long-term investment-grade marketable debt instruments, and $46.9 million of net accounts receivable. Total assets were $253.0 million and total liabilities were $33.2 million.
The company had no revolving loans outstanding under its $50.0 million JPMorgan credit facility. Letters of credit utilized $21.8 million of the $30.0 million available LC component, with $19.9 million of outstanding letters of credit. The company was in compliance with its debt covenants.
Material changes versus the prior comparable period
- Revenue increased modestly, but profitability declined because gross margin fell and operating expenses increased.
- Gross margin decreased primarily because of higher manufacturing costs, partially offset by product mix and lower freight and tariffs.
- Total operating expenses increased 8.8% to $68.0 million, driven mainly by higher headcount, wages, benefits and share-based compensation.
- Sales and marketing expense increased to $22.2 million from $16.3 million, reflecting greater investment in the CO2 market and related commercial activities.
- Research and development expense decreased to $17.0 million from $17.9 million, partly because 2022 included VorTeq-related accelerated depreciation and severance costs.
- Interest income increased to $3.8 million from $0.9 million because of higher investment yields and a larger marketable-securities portfolio.
- The effective tax rate declined to 5% from 8%, helped by increased Foreign-Derived Intangible Income and research-and-development tax benefits.
- Operating cash flow more than doubled, helped by collections, lower inventory investment and the timing of vendor payments. Financing cash flow was positive in 2023, compared with a $23.7 million use in 2022, when the company repurchased $26.7 million of stock.
- Net inventory declined to $26.1 million from $28.4 million, although the inventory valuation adjustment increased to $1.2 million from $0.5 million.
Guidance, outlook, management commentary and risks
Management expects existing cash, investments and operating cash generation to satisfy anticipated liquidity needs for at least the next 12 months. Additional debt or equity financing could be required for acquisitions or investments associated with rapid adoption of new technologies. The filing does not provide a clear numerical 2024 revenue or earnings guidance range.
Management expects increased sales and marketing expenditures in 2024 and 2025. Strategic priorities include expanding wastewater adoption, commercializing the PX G1300, advancing ultra-high-pressure reverse-osmosis products and continuing research and development in new pressure-exchanger applications.
- Water revenue depends heavily on large desalination projects, whose timing is affected by financing, permitting, government priorities, geopolitical conditions and project execution.
- Revenue and cash flow can fluctuate significantly because of long sales cycles and the timing of megaproject shipments. Large-project contracts commonly include holdbacks of 10% or less, with final payments potentially delayed 24 to 36 months after delivery.
- Competition is increasing in desalination and wastewater energy-recovery products and may pressure market share, pricing and margins.
- Wastewater and CO2 refrigeration products remain subject to uncertain market adoption, customer qualification cycles and competing technologies.
- The company relies on a limited number of suppliers for certain critical materials and components and may face quality, capacity, delivery or cost risks.
- International exposure creates sensitivity to Middle East and Asian markets, foreign-exchange movements, trade restrictions, tariffs, export controls and geopolitical conflicts.
- Manufacturing facilities are exposed to earthquake, public-safety power-shutdown and other business-interruption risks.
- Letters of credit support product warranty and performance guarantees. The company also has $13.3 million of operating lease liabilities and approximately $1.5 million of cancellable purchase-order commitments.
- No material litigation losses were probable or reasonably possible at December 31, 2023. The company reported no cybersecurity risks that had materially affected, or were reasonably likely to materially affect, its business, results or financial condition.
Deloitte & Touche issued unqualified opinions on the financial statements and internal control over financial reporting. Revenue recognition was identified as the critical audit matter because of the volume of transactions and manual review required to determine when control transferred to customers.
Most important facts for investors to verify
- Whether megaproject timing and Middle East and Africa activity support revenue growth after the modest 2023 increase.
- Whether gross margin recovers from 67.8% while sales, marketing and research investments continue to rise.
- Evidence of sustained commercial adoption and revenue growth for wastewater products and the PX G1300.
- Cash conversion, accounts-receivable collections and the timing of contract holdback payments.
- Utilization of the credit facility and letters of credit, covenant compliance and potential obligations under performance guarantees.
- Customer and supplier concentration, including the disclosed 13% contribution from one 2023 customer and three major suppliers representing 10% or more of manufacturing purchases.
- The potential effect of inventory obsolescence, warranty claims, tax-credit realizability and unrecognized tax benefits of $1.7 million.
- Future operating-expense levels, capital requirements and whether acquisitions or accelerated technology investment could require external financing.